|
LUC7L3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.03999999995419E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66619999999651E-05 |
| Normal-vs-Stage2 |
1.118030E-01 |
| Normal-vs-Stage3 |
6.611000E-01 |
| Normal-vs-Stage4 |
2.323400E-01 |
| Stage1-vs-Stage2 |
9.313400E-01 |
| Stage1-vs-Stage3 |
1.435570E-03 |
| Stage1-vs-Stage4 |
7.724400E-01 |
| Stage2-vs-Stage3 |
1.598840E-01 |
| Stage2-vs-Stage4 |
8.064200E-01 |
| Stage3-vs-Stage4 |
3.059000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.87381999999792E-05 |
| Normal-vs-AfricanAmerican |
3.241200E-03 |
| Normal-vs-Asian |
8.267700E-02 |
| Caucasian-vs-AfricanAmerican |
9.824000E-01 |
| Caucasian-vs-Asian |
8.084400E-01 |
| AfricanAmerican-vs-Asian |
8.133200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.2751000000063E-06 |
| Normal-vs-Female |
3.723200E-03 |
| Male-vs-Female |
6.702200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.622200E-02 |
| Normal-vs-Extreme_Weight |
1.784630E-03 |
| Normal-vs-Obese |
5.436000E-03 |
| Normal-vs-Extreme_Obese |
7.917700E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.989400E-01 |
| Normal_Weight-vs-Obese |
8.281400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.904000E-01 |
| Extreme_Weight-vs-Obese |
7.895600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.883600E-01 |
| Obese-vs-Extreme_Obese |
8.941200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.457700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.03660000033901E-07 |
| Normal-vs-Age(61-80Yrs) |
2.299300E-03 |
| Normal-vs-Age(81-100Yrs) |
8.753600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.372400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.089400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.087170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.243780E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.926300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.625830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.87439977270299E-10 |
| Normal-VS-Type2 PRCC |
4.033200E-01 |
| Normal-VS-KIRP CIMP |
6.479600E-01 |
| Normal-VS-Unclassified PRCC |
3.796400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.1803003019395E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.4473999999941E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.373800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.113800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.228170E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.327800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.004400E-02 |
| Normal-vs-N1 |
8.505900E-02 |
| Normal-vs-N2 |
8.661400E-01 |
| N0-vs-N1 |
5.595200E-01 |
| N0-vs-N2 |
5.094200E-01 |
| N1-vs-N2 |
4.140200E-01 |
|
|
